Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results

scientific article published in June 2015

Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/JTO.0000000000000525
P698PubMed publication ID26001145

P50authorYuta ShibamotoQ61146833
P2093author name stringChisa Hashizume
Akifumi Miyakawa
Fumiya Baba
Shiho Ayakawa
Taro Murai
Yukiko Hattori
Ryuji Asai
Taiki Takaoka
P433issue6
P921main subjectlung cancerQ47912
adaptive radiation therapyQ180507
P304page(s)960-964
P577publication date2015-06-01
P1433published inJournal of Thoracic OncologyQ2448056
P1476titleStereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results
P478volume10

Reverse relations

cites work (P2860)
Q47877896A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors
Q37601070Characterization of in vitro radiosensitization in mammalian cells using biomathematical modelling: implications for hypofractionated radiotherapy with a combined modality approach
Q57282048Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer
Q38685007Comparative Analysis of Local Control Prediction Using Different Biophysical Models for Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy.
Q90136503Comparison of Three Radiobiological Models in Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer
Q48308100Comparison of multileaf collimator and conventional circular collimator systems in Cyberknife stereotactic radiotherapy
Q36382039Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
Q58735983Definitive Radiotherapy With SBRT or IMRT Boost for Breast Cancer: Excellent Local Control and Cosmetic Outcome
Q64969902Early stage lung cancer survival after wedge resection and stereotactic body radiation.
Q37443984Efficacy of stereotactic radiotherapy for brain metastases using dynamic jaws technology in the helical tomotherapy system
Q55345592Guidelines for stereotactic body radiation therapy treatment of lung cancer highlight important research questions: what is the next step?
Q49891068Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience
Q90160118Hypofractionated carbon-ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study
Q90999580Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors
Q61804649Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes
Q49749018Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation
Q36363955Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy
Q37458027Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer
Q38785871Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
Q64946137Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT.
Q58718514Stereotactic Body Radiotherapy as an Alternative to Definitive Surgery in Cancers of Various Organs
Q60912983Stereotactic body radiation therapy for non-small cell lung cancer: A review
Q64922876Stereotactic body radiation therapy versus surgery for early stage non-small cell lung cancer: clearing a path through an evolving treatment landscape.
Q55062398Stereotactic body radiation therapy vs. surgery in early-stage non-small cell lung cancer: lessons learned, current recommendations, future directions.
Q41273661Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study.
Q89966806The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
Q61804644The current and future faces of stereotactic body radiation therapy for thoracic malignancies
Q50138849The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer
Q90329625Weighing the relative importance of short-term versus long-term outcomes when comparing surgery versus stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer

Search more.